- IN₹1.03tn
- IN₹1.06tn
- IN₹142.78bn
Indian drugmaker Mankind Pharma posts higher quarterly profit on strong chronic drugs demand
Brief: Mankind Pharma Q3 Consol Net Profit 4.09 Billion Rupees
Brief: Mankind Pharma Recieves Tax Penalty Of 153.2 Million Rupees
India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs
India's Mankind Pharma falls on lower quarterly profit
Mankind Pharma posts fourth straight quarterly profit fall on sales hit from tax cuts
Brief: Mankind Pharma Q2 Consol Net Profit 5.12 Billion Rupees
Brief: Mankind Pharma Says Business Transfer Agreement Between Co, Bharat Serums & Vaccines
Quotes: Reactions after India cuts consumption tax on hundreds of items
Quotes: Reactions after India cuts consumption tax on hundreds of items
Brief: Mankind Pharma Says Wholly Owned Subsidiary Has Been Incorporated In Russia
Domestic buying, likely earnings rebound to boost Indian shares in near-term: Jefferies
India's Mankind Pharma posts lower quarterly profit as costs surge
Brief: Mankind Pharma Q1 Consol Net Profit 4.38 Billion Rupees
Brief: Mankind Pharma Incorporates Wholly Owned Subsidiary In Sri Lanka
India's Mankind Pharma rises as Jefferies raises target on growth revival hopes
Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market
India's Mankind Pharma drops on lower quarterly margins
India's Mankind Pharma beats profit estimates on demand for drugs to treat chronic illnesses